Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05320042 · ClinicalTrials.gov registry record · NA
1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT05320042 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 28 participants.
The verdict
NCT05320042, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Baseline Visit at which informed consent will be obtained and eligibility will be assessed.
Interventions
- DEVICE kalifilcon A Daily Disposable Toric
- DEVICE Ultra for Astigmatism Contact Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2022-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05320042
The ClinicalTrials.gov registry entry for NCT05320042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which kalifilcon A Daily Disposable Toric is the first listed.
NCT05320042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05320042 about?
NCT05320042 is a clinical study titled "1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism". Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Baseline Visit at which informed consent will...
What is the current status of trial NCT05320042?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-02-14. Estimated completion is 2022-05-10.
What interventions are being tested in trial NCT05320042?
The interventions under investigation include: kalifilcon A Daily Disposable Toric (DEVICE), Ultra for Astigmatism Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT05320042?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.